Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
AutismSevere Behavior Disorder
Interventions
DRUG

placebo

50 mL of 1/2 normal saline IV

DRUG

glutathione

glutathione 600 mg IV

DRUG

glutathione, vit C and NAC

Glutathione 600 mg IV Vitamin C 2000 mg IV N-acetylcysteine 20 mg/kg IV (max dose = 600 mg) Mix above three in 1/2 NS for a total volume of 50 mL

Trial Locations (1)

40202

KCPCRU, Louisville

All Listed Sponsors
collaborator

Cumberland Pharmaceuticals

INDUSTRY

collaborator

Norton Healthcare

OTHER

lead

University of Louisville

OTHER

NCT00889538 - Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems | Biotech Hunter | Biotech Hunter